Luisa E. Schwarzmuller
Heidelberg, BW 69120, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Correction: GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.
Journal: Clinical epigenetics
Published: July 10, 2026
PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model.
Journal: Molecular oncology
Published: September 10, 2025
Comparison of In-Gel and SP3 Based Sample Preparation Protocols for LC-MS/MS Based Proteomics.
Journal: Proteomics
Published: September 10, 2025
Re-epithelialization of cancer cells increases autophagy and DNA damage: Implications for breast cancer dormancy and relapse.
Journal: Science signaling
Published: April 22, 2025
Multicenter evaluation of label-free quantification in human plasma on a high dynamic range benchmark set.
Journal: Nature communications
Published: December 10, 2024
Comparing genome-scale metabolic models of the non-resistant Enterococcus faecalis ATCC 19433 and the multi-resistant Enterococcus faecalis V583.
Journal: Journal of biotechnology
Published: November 21, 2023
Cell-to-cell variability in JAK2/STAT5 pathway components and cytoplasmic volumes defines survival threshold in erythroid progenitor cells.
Journal: Cell reports
Published: December 06, 2020
The ParaHox gene Cdx4 induces acute erythroid leukemia in mice.
Journal: Blood advances
Published: July 29, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026